PDI 2009 ISDP LAC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 16(6): 617-622 1996
© 1996 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rocco, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rocco, M.
Peritoneal Dialysis International, Vol 16, Issue 6, 617-622
Copyright © 1996 by International Society for Peritoneal Dialysis


Articles

Body surface area limitations in achieving adequate therapy in peritoneal dialysis patients

MV Rocco

Department of Internal Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina, USA.

OBJECTIVE: To estimate the maximal body surface area (BSA) at which anuric chronic peritoneal dialysis patients can achieve adequate peritoneal dialysis using a variety of continuous ambulatory peritoneal dialysis (CAPD) and cycler regimens. Adequate dialysis was defined as a creatinine clearance of either 60 L/week/1.73 m2 or 70 L/ week/1.73 m2. DESIGN: Calculation of daily peritoneal creatinine clearances using standard formulas. For CAPD patients, creatinine clearance was calculated using published values for dialysate-to-plasma ratios for creatinine (D/P cr) measured over a 24-hour period and assuming a daily ultrafiltration rate of 1.5 to 2.0 L/day. For cycler patients, creatinine clearance was calculated for both one- and two-hour dwell volumes, using published values for D/P cr from the peritoneal equilibration test and assuming a daily ultrafiltration rate of 2.0 L/day. All clearances were corrected to a normalized body surface area of 1.73 m2. RESULTS: For CAPD patients, 2-L dwell volumes can provide a weekly creatinine clearance of 60 L/week/1.73 m2 in patients with BSA < 1.45 m2 in the high transporter group and with BSA < 1.2 m2 in the low-average transporter group. Increasing dwell volume from 2.0 to 2.5 L increases these BSA limits in the four transport groups by 0.2-0.3 m2. Cycler therapy is not a viable option for patients in the low transporter group, and this therapy can achieve adequate creatinine clearances in patients in the low-average transport group only with large dwell volumes and in patients with BSA < 1.55 m2. However, in the high-average and high transporter groups, cycler therapy provides for superior creatinine clearances compared to CAPD patients using similar dwell volumes. CONCLUSIONS: Adequate creatinine clearances in anuric patients are most likely to be achieved in patients with BSA > 2.0 m2 if they have high-average or high transport characteristics and are receiving cycler therapy with large dwell volumes and at least one daytime dwell. However, adequate creatinine clearances may be difficult to achieve in anuric patients who have a large BSA and a low or low-average transport type, regardless of peritoneal dialysis modality. These patients should be considered for either high-dose peritoneal dialysis (multiple daytime and nighttime exchanges) or hemodialysis therapy.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
E. A. Brown, S. J. Davies, P. Rutherford, F. Meeus, M. Borras, W. Riegel, J. C. Divino Filho, E. Vonesh, and M. Van Bree
Survival of Functionally Anuric Patients on Automated Peritoneal Dialysis: The European APD Outcome Study
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2948 - 2957.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. H. TZAMALOUKAS, G. H. MURATA, B. PIRAINO, D. MALHOTRA, J. BERNARDINI, P. RAO, and D. G. OREOPOULOS
The Relation Between Body Size and Normalized Small Solute Clearances in Continuous Ambulatory Peritoneal Dialysis
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1575 - 1581.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 1996 by Multimed Inc.